Human Papillomavirus (HPV) is the most common sexually transmitted virus. Worldwide, the
most common high-risk (HR)-HPV are-16/18, and approximately 70% of cervical cancers …

Background Atypical squamous cells of undetermined significance (ASCUS) and low‐grade
squamous intra‐epithelial lesions (LSIL) are minor lesions of the cervical epithelium …

ABSTRACT Introduction: Human papillomavirus (HPV)-related cancers can be averted by
type-specific vaccination (primary prevention) and/or through detection and ablation of …

Persistent infection with high-risk human papillomavirus (HPV) genotypes is the leading
cause of cervical cancer development. To this end several studies have focused on …

Objective: Human papillomavirus (HPV) is responsible for a range of diseases, including
cervical cancer. The primary objectives of the CLEOPATRE Portugal study were to estimate …

We aimed to determine the disagreement in primary cervical screening between four human
papillomavirus assays: Hybrid Capture 2, cobas, CLART, and APTIMA. Material from 5,064 …

Mucosal infection by the human papillomavirus (HPV) is responsible for a growing number
of malignancies, predominantly represented by cervical cancer and oropharyngeal …

In women aged≥ 30 years, Human Papillomavirus testing will replace cytology for primary
cervical screening. We compared Hybrid Capture 2 (HC2), cobas, CLART, and APTIMA HPV …

Greater understanding of the role played by human papillomavirus (HPV) in the causation of
disease has led to the development of an increasing number of HPV tests with different …

Persistent positivity of HPV-DNA testing is considered a prognostic index of recurrent
disease in patients treated for CIN2+. HPV detection, and particularly genotyping, has an …